Sometimes life renders our skin damaged, aesthetically displeasing and functionally compromised. This can lead to restricted lifestyles, lower quality of life and mental distress. Over 100 million patients acquire scars from surgeries yearly, and millions suffer from traumatic skin defects. In addition, our skin is affected by aging and environmental factors. Linio Biotech is dedicated to change this for millions of people. After more than a decade of research and development, a sterile cell-free innovation for tissue regeneration is available for those suffering from severe scars, other skin defects and aged skin.

DIBL is a new dilemma-based learning platform that empowers facilitators online or offline to easily create and deliver active learning. Our vision is to create a new category for dilemmas similar to what we know from quizzes. We believe that the future of learning holds collaboration over competition, reflecting rather than remembering, multiple truths above one truth, and involvement rather than engagement

Med idékraft, teknologi og entreprenørskap, tar vi drømmer ned på jorda og gir dem bein å gå på. Utvikling av nye produkter og tjeneser: Vi hjelper virksomheter med å utvikle produkter og tjenester, basert på hva kundene er opptatt av og villige til å betale for. Vi tar idéen hele veien fra tegnebrettet til markedet, og sikrer en effektiv prosess fra A-Å. Vekststrategi Vi utvikler strategier som er enkle å forstå og motiverende å gjennomføre. Skal du realisere ny strategi eller nye initiativ trenger du gjerne fart og kraft. Våre rådgivere, med strategisk og operativ erfaring, tar dine prosjekter fra plan til virkelighet – raskere.

Lunsjkollektivet er en fleksibel og digital kantineløsning, som skal revolusjonere jobblunsjen. Vi har store planer for vekst de neste årene og skal etablere oss internasjonalt. Lunsjkollektivet ble gründet høsten 2017, og leverer i dag jobblunsj til bedrifter i Oslo og Bergen.Det å ta grønne valg i drift ligger i ryggmargen vår og dette skinner igjen i alle valg vi gjør. I alt fra hvordan vi velger å utvikle i plattformen vår, boksene maten vår serveres i til innholdet i hver lunsjrett.

More than 2 billion photos are shared on SoMe every day. Photo and video are the World’s largest hobby and have become one of the strongest means of communication. Cameralla is a unique digital platform and online community for people interested in taking better photos and in increasing the value of their photos. We give our members the opportunity to LEARN how to take better photos through our online courses, SHARE their photos with the community on our photo-sharing platform and EXPLORE unique photo locations and unlock hidden treasures – and much much more! Cameralla soft-launched in Norway at the end of 2020 and already has more than 15.000 members. The platform and content are ready in both Norwegian and English and we are ready to grow in an international billion-dollar market.

Vi er Nolo Nordic og vi gjør alkoholfritt mer spennende, sofistikert, gøy og smakfullt ved å produsere førsteklasses drikkevarer under merkenavnene ALT. og Ambijus. Akkurat nå brygger vi nye nettsider, men besøk gjerne linkene over for å lære mer om våre prisvinnende og kompromissløse alkoholfrie drikker.

Disruptive Engineering enables more effective planning, management, and monitoring of road networks. Proprietary sensor hardware 'made in Norway'Use AI and neural networks for detailed classification of vehicles. Privacy-by-design solution ensuring that no personal data is stored or shared. With traffic expected to grow by 60% by 2050, and with congestion and safety already being an issue, there is a pressing need to utilize road networks more efficiently. Both Statens Vegvesen and Nye Veier see our first sensor VS1, and the valuable data it provides, as a potential solution to achieve this as well as an opportunity to digitalize roads and infrastructure for the forthcoming Intelligent Transportation Systems (ITS) that are being implemented across Europe.Statens Vegvesen linkNye Veier link

Renteradar monitors our users' mortgage rates over time and compares them to the offers available in the market. We want to make the process of monitoring and comparing mortgage rates as easy as possible by creating transparency. We automatically match our users with their cheapest lenders as well as assist in the following transition. Our system uses BankID to collect the required information which makes the experience as effortless and uncomplicated as possible.

People find going to the optician frustrating and it is something they tend to delay as long as possible. Pain points include complicated, non-transparent pricing, lack of understanding about lenses and the options available, and insecurity when choosing glasses. Our mission is to remove these pain points and provide a more relevant modern alternative to the traditional optician. Our vertical concept allows us to offer high-quality designer eyewear at affordable prices - enabling people to build a collection of eyewear to meet the needs of their individual lifestyles. We are currently generating 14 million Nok in sales per year through our 5 Kaibosh stores (Oslo, Bergen, Copenhagen, Frederiksberg & Aarhus), e-commerce operation, and wholesale distribution channels.

VR is changing the way we learn with spacial mnemonics encoding trigging memory intimacy and presence - VR tech makes it possible to learn better and faster. Making View has the smartest and boldest people with an international company track record and solutions developed in cooperation with researches and clients. Making View is the improvisation master in the VR tech world creating harmonious learning environments - We will provide a scalable business model based on annual licenses.

Iterate is an ecosystem for digital innovation, and we like to describe ourselves as a company that builds companies. We contribute from A-Z when building, starting with creating concepts based on key insights to launching and improving products whilst living in the marketplace. We find the right team and work toward the company culture that enables us to deliver value to our customers quickly. The key to achieving this is reinvesting all our profits in the ideas of our employees, or selected entrepreneurs. Five years into this strategy, we own shares in fifteen ventures; all of which are showing promising results. Our 70 designers, developers, and product managers just moved into new locations in the center of Oslo. 
Close collaboration with our customers is key to our success. They provide domain know-how, and we provide tools, strategies, and experts. Together we uncover the best way that connects your strategy and idea with the market needs. Our goal is to achieve minimum risk and give our customers the best possible starting point for scaling, on their own, or in continued collaboration.

CardiNor AS er et norsk bioteknologiselskap etablert for å håndtere kommersialiseringen av secretoneurin, en ny biomarkør test for hjertekar sykdom. Vår innovasjon er en ny og proprietær hjertekar test – secretoneurin. Secretoneurin er vist å ha sterk prognostisk nytteverdi hos pasienter med hjertesvikt, og den har et særskilt stort potensial hos pasienter med hjerterytmeforstyrrelser (arytmi). Hjertekar sykdom er fortsatt den viktigste dødsårsaken i verden i dag. Ingen av de kjent og etablerte biomarkørene for hjertekar sykdom er til særlig hjelp i valg av medisinske, og eller kirurgiske behandlingsmetoder for å forhindre livstruende hjerterytmeforstyrrelser. Selskapet utvikler nå en brukervennlig forskningstest for å måle secretoneurin blod som vil markedsført og solgt gjennom et nettverk av distributører i Europa og USA. Dette etterfulgt av introduksjonen av et CE-merket produkt for klinisk bruk i Europa og regulatorisk godkjenning i USA. CardiNor-ledelsen har inngående kunnskap om og erfaring fra bioteknologi og diagnostisk industri som dekker hele livssyklus fra oppstart til exit. CardiNor samarbeider med verdensledende akademiske institusjoner og opinionsledere og industri i å utvikle og dokumentere biomarkør testen.

Oncoinvent AS is a privately held Norwegian company established in 2010. The company is committed to developing new innovative products to provide better treatment options to cancer patients. The innovations being developed by Oncoinvent AS are a result of the extensive experience with the development of radionuclide-based cancer treatments of two of the founders, Dr. Roy H. Larsen and Professor of clinical oncology Øyvind S. Bruland. Larsen and Bruland are the inventors of the first FDA and EMA-approved alpha-emitting pharmaceutical product Xofigo® (Bayer AG), as well as of the beta-emitting radio-immunotherapeutic product candidate Betalutin® (Nordic Nanovector ASA). Oncoinvent's lead product candidate, Radspherin®, is a novel alpha-emitting radioactive microsphere designed for the treatment of metastatic cancers in body cavities. Radspherin® has been shown to cause a significant reduction in tumor cell growth. It is anticipated that the product can potentially treat several forms of metastatic cancer. The first clinical indication for Radspherin® will be the treatment of peritoneal carcinomatosis. Clinical development will be conducted in collaboration with European and American clinical research centers.

“SevenSix is a learning and development platform to empower tennis players through their careers. It will be a holistic service, transforming data into knowledge about strengths and opportunities, to optimize how the player exercises, competes, eats, sleeps, thinks and is motivated. This is done by gathering, transforming, combining, and visualizing ALL relevant data, bridging science and technology combined with methodology and experience. ”MVBP is ready and is beeing tested on the national team of tennis and Stavanger Tennisklubb. The development is supported by Microsoft and Capgemini.SevenSix will be distributed to 100 million tennis players with membership in Tennis Federations.

A7 was founded in USA late 2015. It was started as a movement dedicated to helping others reaching their full potensial. On the back of all the shirts there is a patented grip that prevents the bar from sliding when you do squats. When you do bench it keeps your body from sliding. Its usable for many other purposes in training as well but that´s the two big ones. 2016 was a true adventure for the Europe company.